Complement killing of human neuroblastoma cells: A cytotoxic monoclonal antibody and its F(ab)'2-cobra venom factor conjugate are equally cytotoxic
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 27 (10), 957-964
- https://doi.org/10.1016/0161-5890(90)90118-j
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Covalent conjugates of monoclonal antibody and cobra venom factor mediate specific cytotoxicity via alternative pathway of human complement activationLeukemia Research, 1987
- Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cellsClinical Immunology and Immunopathology, 1987
- Antibody conjugates with cobra venom factorJournal of Immunological Methods, 1987
- MHC Class III products: an electron microscopic study of the C3 convertases of human complement.The Journal of Experimental Medicine, 1984
- Reaction Mechanisms of β1H GlobulinInternational Archives of Allergy and Immunology, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- Modulation of the alternative complement pathways by beta 1 H globulin.The Journal of Experimental Medicine, 1976
- Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.The Journal of Experimental Medicine, 1976
- The Serine Protease Nature of the C3 and C5 Convertases of the Classical and Alternative Complement PathwaysScandinavian Journal of Immunology, 1976
- Cobra Venom Factor: Evidence for Its Being Altered Cobra C3 (the Third Component of Complement)Science, 1976